Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
US Weekly on MSN6d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
A now-former Iowa paramedic is facing charges after allegedly giving a man in need the wrong medication — and then failing to ...
IFLScience on MSN13d
Ketamine's Potential To Treat Depression Beautifully Shown In Struggling ZebrafishKetamine’s promising potential to ease depression is one of the reasons why its use has recently skyrocketed in the US and ...
Lancashire Police are investigating after a man allegedly handed out vapes 'laced with spice and ketamine' at schools.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback